Literature DB >> 12555161

Ventricular remodeling in heart failure.

Mohamed A Gaballa1, Steven Goldman.   

Abstract

This review briefly highlights the major mechanisms of left ventricular (LV) remodeling following myocardial infarction in heart failure and presents novel strategies to limit infarct size and retard the progression of LV remodeling. This is important since interventions that have been shown to improve mortality in patients with heart failure such as angiotensin converting enzyme inhibitor and beta-blockers had a favorable impact on the LV remodeling process. Although several other animal models of heart failure are available, we chose the rat infarct model because of its accurate reflection of human pathophysiology. It is clear from this review that the understanding of the mechanisms responsible for the regression of ventricular remodeling is still unclear. Further investigations in this area will certainly lead to the development of new therapy for heart failure.

Entities:  

Mesh:

Year:  2002        PMID: 12555161     DOI: 10.1054/jcaf.2002.129270

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  19 in total

Review 1.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

2.  A new model of congestive heart failure in rats.

Authors:  Jiqiu Chen; Elie R Chemaly; Li Fan Liang; Thomas J LaRocca; Elisa Yaniz-Galende; Roger J Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-17       Impact factor: 4.733

Review 3.  Molecular changes occurring during reverse remodelling following left ventricular assist device support.

Authors:  Emma J Birks; Robert S George
Journal:  J Cardiovasc Transl Res       Date:  2010-09-04       Impact factor: 4.132

4.  Abnormalities of capillary microarchitecture in a rat model of coronary ischemic congestive heart failure.

Authors:  Jiqiu Chen; Elisa Yaniz-Galende; Heather J Kagan; Lifan Liang; Saboor Hekmaty; Chiara Giannarelli; Roger Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-06       Impact factor: 4.733

5.  Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs).

Authors:  D Dirk Bonnema; Carson S Webb; Weems R Pennington; Robert E Stroud; Amy E Leonardi; Leslie L Clark; Catherine D McClure; Laura Finklea; Francis G Spinale; Michael R Zile
Journal:  J Card Fail       Date:  2007-09       Impact factor: 5.712

6.  Preservation of Functional Microvascular Bed Is Vital for Long-Term Survival of Cardiac Myocytes Within Large Transmural Post-Myocardial Infarction Scar.

Authors:  Colleen Nofi; Yevgen Bogatyryov; Eduard I Dedkov
Journal:  J Histochem Cytochem       Date:  2017-11-08       Impact factor: 2.479

Review 7.  Left atrial remodelling contributes to the progression of asymptomatic left ventricular systolic dysfunction to chronic symptomatic heart failure.

Authors:  George Karayannis; George Kitsios; Haralambos Kotidis; Filippos Triposkiadis
Journal:  Heart Fail Rev       Date:  2007-04-21       Impact factor: 4.214

Review 8.  Postconditioning: a mechanical maneuver that triggers biological and molecular cardioprotective responses to reperfusion.

Authors:  Jakob Vinten-Johansen
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

9.  Implantation of a three-dimensional fibroblast matrix improves left ventricular function and blood flow after acute myocardial infarction.

Authors:  Hoang M Thai; Elizabeth Juneman; Jordan Lancaster; Tracy Hagerty; Rose Do; Lisa Castellano; Robert Kellar; Stuart Williams; Gulshan Sethi; Monika Schmelz; Mohamed Gaballa; Steven Goldman
Journal:  Cell Transplant       Date:  2009       Impact factor: 4.064

10.  Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators.

Authors:  Douglas G Johns; Zhaohui Ao; Diane Naselsky; Christopher L Herold; Kristeen Maniscalco; Lea Sarov-Blat; Klaudia Steplewski; Nambi Aiyar; Stephen A Douglas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-30       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.